Suppr超能文献

线粒体动态与胰岛素分泌。

Mitochondrial Dynamics and Insulin Secretion.

机构信息

Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara 391760, India.

The Arrhenius Laboratories F3, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, SE-106 91 Stockholm, Sweden.

出版信息

Int J Mol Sci. 2023 Sep 7;24(18):13782. doi: 10.3390/ijms241813782.

Abstract

Mitochondria are involved in the regulation of cellular energy metabolism, calcium homeostasis, and apoptosis. For mitochondrial quality control, dynamic processes, such as mitochondrial fission and fusion, are necessary to maintain shape and function. Disturbances of mitochondrial dynamics lead to dysfunctional mitochondria, which contribute to the development and progression of numerous diseases, including Type 2 Diabetes (T2D). Compelling evidence has been put forward that mitochondrial dynamics play a significant role in the metabolism-secretion coupling of pancreatic β cells. The disruption of mitochondrial dynamics is linked to defects in energy production and increased apoptosis, ultimately impairing insulin secretion and β cell death. This review provides an overview of molecular mechanisms controlling mitochondrial dynamics, their dysfunction in pancreatic β cells, and pharmaceutical agents targeting mitochondrial dynamic proteins, such as mitochondrial division inhibitor-1 (mdivi-1), dynasore, P110, and 15-oxospiramilactone (S3).

摘要

线粒体参与细胞能量代谢、钙稳态和细胞凋亡的调节。为了进行线粒体质量控制,线粒体的分裂和融合等动态过程是维持其形态和功能所必需的。线粒体动力学的紊乱会导致功能失调的线粒体,从而促进包括 2 型糖尿病(T2D)在内的多种疾病的发生和发展。有强有力的证据表明,线粒体动力学在胰岛β细胞的代谢-分泌偶联中起着重要作用。线粒体动力学的破坏与能量产生缺陷和细胞凋亡增加有关,最终损害胰岛素分泌和β细胞死亡。本综述概述了控制线粒体动力学的分子机制、其在胰岛β细胞中的功能障碍以及针对线粒体动力学蛋白的药物制剂,如线粒体分裂抑制剂-1(mdivi-1)、dynasore、P110 和 15-氧代螺旋霉素内酯(S3)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc43/10530730/04e4f79dde77/ijms-24-13782-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验